Corey J. Manley - 15 Mar 2026 Form 4 Insider Report for OMNICELL, INC. (OMCL)

Role
EVP&CHIEF LEGAL/ADMIN OFFICER
Signature
/s/ Eric G. Lehmann, Attorney-in-Fact for Corey J. Manley
Issuer symbol
OMCL
Transactions as of
15 Mar 2026
Net transactions value
-$256,879
Form type
4
Filing time
17 Mar 2026, 16:05:14 UTC
Previous filing
18 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Manley Corey J EVP&CHIEF LEGAL/ADMIN OFFICER OMNICELL, INC., 4220 NORTH FREEWAY, FORT WORTH /s/ Eric G. Lehmann, Attorney-in-Fact for Corey J. Manley 17 Mar 2026 0001928727

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMCL Common Stock Award +22,445 +26% $0.000000* 107,941 15 Mar 2026 Direct F1
transaction OMCL Common Stock Tax liability -3,819 -3.5% $34.40* 104,122 15 Mar 2026 Direct F2
transaction OMCL Common Stock Sale $256,879 -7,405 -7.1% $34.69 96,717 16 Mar 2026 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Reflects performance-based restricted stock units that were previously granted on March 15, 2025, subject to the Company meeting certain stock performance objectives compared to the S&P 1000 Healthcare Index. On March 5, 2026 (the determination date), the Compensation Committee determined the performance criteria was met with respect to 22,445 performance-based restricted stock units (100% of target) of which 25% vested upon the one year anniversary of the grant date. The remaining performance-based restricted stock units will vest in equal quarterly increments once every three months over a three-year period (on each May 15, August 15, November 15, and February 15, respectively).
F2 Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.
F3 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025.
F4 The price reported in Column 4 is an exact price of $34.69 for all shares sold.